{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "PRE", "regularMarketPrice": 1.38, "exchangeTimezoneShortName": "EDT", "exchangeTimezoneName": "America/New_York", "currency": "USD", "market": "us_market", "esgPopulated": false, "messageBoardId": "finmb_37613299", "gmtOffSetMilliseconds": -14400000, "shortName": "Cellectar Biosciences, Inc.", "longName": "Cellectar Biosciences, Inc.", "regularMarketChangePercent": 0.0, "exchange": "NCM", "regularMarketChange": 0.0, "regularMarketTime": 1684180543, "regularMarketDayHigh": 1.4, "regularMarketDayRange": "1.37 - 1.4", "regularMarketDayLow": 1.37, "regularMarketVolume": 52299, "regularMarketPreviousClose": 1.38, "bid": 0.0, "ask": 0.0, "bidSize": 10, "askSize": 10, "fullExchangeName": "NasdaqCM", "financialCurrency": "USD", "regularMarketOpen": 1.37, "averageDailyVolume3Month": 59748, "averageDailyVolume10Day": 66210, "fiftyTwoWeekLowChange": 0.13, "averageAnalystRating": "1.6 - Buy", "tradeable": false, "cryptoTradeable": false, "fiftyTwoWeekLowChangePercent": 0.103999995, "fiftyTwoWeekRange": "1.25 - 6.76", "fiftyTwoWeekHighChange": -5.38, "fiftyTwoWeekHighChangePercent": -0.79585797, "fiftyTwoWeekLow": 1.25, "fiftyTwoWeekHigh": 6.76, "dividendDate": 1531785600, "earningsTimestamp": 1683204000, "earningsTimestampStart": 1691065800, "earningsTimestampEnd": 1691411400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.81, "epsForward": -2.83, "epsCurrentYear": -3.91, "priceEpsCurrentYear": -0.35294116, "sharesOutstanding": 9740510, "bookValue": 1.505, "fiftyDayAverage": 1.505, "fiftyDayAverageChange": -0.125, "fiftyDayAverageChangePercent": -0.08305648, "twoHundredDayAverage": 2.4536, "twoHundredDayAverageChange": -1.0735999, "twoHundredDayAverageChangePercent": -0.43756112, "marketCap": 13441904, "forwardPE": -0.4876325, "priceToBook": 0.91694355, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "firstTradeDateMilliseconds": 1131633000000, "priceHint": 4, "displayName": "Cellectar Biosciences", "symbol": "CLRB"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "100 Campus Drive", "city": "Florham Park", "state": "NJ", "zip": "07932", "country": "United States", "phone": "608 441 8120", "website": "https://www.cellectar.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r pediatric patients with head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Mr. James V. Caruso", "age": 63, "title": "Pres, CEO & Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 846475, "fmt": "846.48k", "longFmt": "846,475"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Chad J. Kolean CPA, CPA", "age": 58, "title": "VP, CFO & Sec.", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 453224, "fmt": "453.22k", "longFmt": "453,224"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jarrod  Longcor", "age": 49, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": {"raw": 625320, "fmt": "625.32k", "longFmt": "625,320"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Darrell Shane Lea", "age": 49, "title": "Chief Commercial Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Andrei  Shustov M.D.", "age": 51, "title": "Sr. VP of Medical", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}